Trial intelligence / Profile preview

DECREASE-IV perioperative bisoprolol and fluvastatin trial in non-cardiac surgery

NL-OMON21523Recruiting

Sponsor
Erasmus MC
Start
Jul 2004
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of bisoprolol and fluvastatin in cardiovascular complications (4 arms), sponsored by Erasmus MC. Primary endpoint: 30-day cardiovascular events. Started Jul 2004; status: recruiting.

02

Drugs

bisoprololfluvastatin
03

Conditions

cardiovascular complications

Beyond the preview

Go deeper on NL-OMON21523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call